Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 |
|---|---|---|---|---|---|---|
| Revenue | 808M | 666M | 534M | 425M | 402M | 337M |
| Cost of revenue | 432M | 406M | 333M | 284M | 281M | 237M |
| Gross profit | 357M | 240M | 182M | 123M | 100M | 78M |
| Research and development | 91M | 80M | 81M | 76M | 74M | 74M |
| Selling, general and administrative | 91M | 96M | 85M | 112M | 76M | 76M |
| Operating expenses | 183M | 176M | 175M | 160M | 151M | 160M |
| Operating income | 175M | 64M | 7M | −38M | −52M | −82M |
| Income tax | 40M | 18M | 1M | 5M | 19M | 3M |
| Net income | 144M | 78M | 4M | −44M | −61M | −82M |
| Earnings per share | 1.99 | 1.10 | 0.06 | −0.64 | −0.88 | −1.21 |
| Earnings per share, diluted | 1.50 | 0.89 | 0.05 | −0.64 | −0.88 | −1.21 |
| Weighted average shares | 72M | 71M | 70M | 69M | 69M | 68M |
| Weighted average shares, diluted | 96M | 88M | 78M | 69M | 69M | 68M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.62B | 658M | 773M | 521M | 516M | 480M | 489M | 437M |
| Short-term investments | 555M | 498M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | — | 58M | — | — | 40M |
| Depreciation and amortisation | 33M | 31M | 28M | 25M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 349M |
| 356M |
| 350M |
| 417M |
| 427M |
| 450M |
| Inventory | 633M | 570M | 532M | 470M | 423M | 402M | 403M | 398M |
| Current assets | 4.40B | 2.28B | 2.09B | 1.72B | 1.67B | 1.65B | 1.64B | 1.59B |
| Goodwill | 1.07B | 1.06B | 1.06B | 1.06B | 1.06B | 1.06B | 1.06B | 1.06B |
| Total assets | 7.03B | 4.81B | 4.61B | 4.22B | 3.98B | 3.97B | 3.97B | 3.93B |
| Current liabilities | 3.87B | 3.77B | 1.53B | 393M | 353M | 347M | 305M | 269M |
| Short-term debt | 3.24B | 3.24B | 1.08B | 11M | 10M | 10M | 11M | 0 |
| Long-term debt | 43M | 47M | 2.16B | 2.56B | 2.56B | 2.56B | 2.57B | 2.50B |
| Total liabilities | 4.05B | 3.96B | 3.83B | 3.08B | 3.10B | 3.09B | 3.07B | 2.97B |
| Equity | 2.97B | 847M | 781M | 1.13B | 880M | 872M | 896M | 957M |
| Shares outstanding | 72M | 71M | 71M | 70M | 69M | 69M | 69M | 68M |
| Shares issued | 72M | 71M | 71M | 70M | 69M | 69M | 69M | 68M |
| 26M |
| 27M |
| Share-based compensation | — | — | 42M | — | — | 36M |
| Capital expenditure | — | — | 76M | — | — | 74M |
| Investing cash flow | — | — | −68M | — | — | −47M |
| Financing cash flow | — | — | 262M | — | — | 60M |